| Overview |
| bs-20341R |
| phospho-Smad2 (Ser250) Polyclonal Antibody |
| WB, ELISA |
| Human, Mouse, Rat |
| Dog, Cow, Pig |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Anti-phospho-Smad2 (Ser250) |
| Ser250 |
| Polyclonal |
| #REF! |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4_. Store at -20_ for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 4087 |
| Q15796 |
| Cytoplasm, Nucleus |
| Mothers against decapentaplegic homolog 2; SMAD2; MAD homolog 2; Mothers against DPP homolog 2; JV18-1; Mad-related protein 2; hMAD-2; SMAD family member 2; MADH2; MADR2 |
| Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD2/SMAD4 complex, activates transcription. May act as a tumor suppressor in colorectal carcinoma. |
| Application Dilution |
| WB |
1:300-5000 |
| ELISA |
1:500-1000 |